When UK Ministers first unveiled plans to diverge from restrictive EU rules classifying gene edited products as GMOs, it was hailed as a major Brexit dividend, giving Britain the freedom to pursue a more enabling, pro-innovation trajectory compared to our counterparts on the continent.